The HANDI team hopes everyone will soon be enjoying all the warmth of the holiday season! To close the year, December HANDI Highlights is dedicated to new and emerging novel technologies for the treatment of people with bleeding disorders.…
Atlanta-based Expression Therapeutics recently announced phase 1 clinical trial results based on ET3, the company’s investigational gene therapy. ET3 is developed with novel lentiviral vectors. This type of therapy uses repurposed…
Dr. Metz has been active and passionately involved with the bleeding disorders since his son with Hemophilia A was born 37 years ago. He served for a total of 26 years on the Board of HFSC including 3 terms as its president. He also was committed to…
Tamsen Bhachech currently serves as Deputy General Counsel of Regulatory Compliance for a global technology company where she's responsible for the organization's overall compliance program. With over twenty years of legal experience, including…
Paul Empey is President and CEO of Precision BioLogic Inc., a niche leader in hemostasis diagnostics and research, based on the east coast of Canada.Originally hailing from Boston, Paul has more than 40 years of experience in senior and executive…
.flexlogos {
margin: 0;
padding: 0;
display: flex;
justify-content: center;
align-items: center;
}
.logo-container {
display: flex;
flex-wrap: wrap;
justify-content: space-around;
max-width: 800px…
Featuring: Dr. Diane Nugent, M.D.Description: Alternative Funding Programs (AFPs) may appear to save costs for employers, but they can create significant risks for patients, particularly those with chronic…
The National Bleeding Disorders Foundation is proud to support an important research initiative led by Emily Agen, a genetic counseling graduate student at the University of Michigan, who is investigating our community's…
Featuring: Dr. Diane Nugent M.D.Description: Alternative Funding Programs (AFPs) may promise cost savings, but they disrupt care for patients with complex medical needs, leading to delays, higher costs, and…
Featuring: Dr. Diane Nugent M.D.Description: Hemophilia Treatment Centers (HTCs) provide a proactive, team-based approach to managing bleeding disorders. Discover how their comprehensive care model supports…